-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Tarsus Pharmaceuticals, Lowers Price Target to $98

Benzinga·07/31/2026 17:40:48
語音播報
Mizuho analyst Graig Suvannavejh maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform and lowers the price target from $100 to $98.